|
PANW
|
Technology |
OTR Global |
Downgrade
|
Positive
→
Mixed
|
—
|
$170.3B
|
$67.27
|
-1.7%
|
-4.3%
|
+0.6%
|
-3.0%
|
-3.1%
|
+1.0%
|
|
PH
|
Industrials |
Deutsche Bank |
Downgrade
|
Buy
→
Hold
|
—
|
$111.0B
|
$300.23
|
-2.2%
|
-0.6%
|
-0.5%
|
+0.5%
|
-0.9%
|
-0.5%
|
|
DUK
|
Utilities |
Vertical Research |
Downgrade
|
Buy
→
Hold
|
—
|
$96.8B
|
$107.93
|
-0.5%
|
-0.9%
|
-0.8%
|
+0.7%
|
+0.2%
|
-1.4%
|
|
NET
|
Technology |
Baird |
Downgrade
|
Outperform
→
Neutral
|
—
|
$72.0B
|
$121.46
|
-3.4%
|
-2.2%
|
+3.9%
|
+1.7%
|
-5.1%
|
+2.7%
|
|
CAH
|
Healthcare |
Deutsche Bank |
Downgrade
|
Buy
→
Hold
|
—
|
$48.2B
|
$50.57
|
-0.2%
|
+0.8%
|
-0.6%
|
+0.6%
|
+1.3%
|
+0.8%
|
|
BDX
|
Healthcare |
JP Morgan |
Downgrade
|
Overweight
→
Neutral
|
—
|
$42.2B
|
$146.47
|
-0.3%
|
-0.8%
|
-1.0%
|
+0.0%
|
+0.9%
|
+2.3%
|
|
EXPE
|
Consumer Cyclical |
JMP Securities |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$28.4B
|
$161.69
|
-7.5%
|
-7.9%
|
-0.1%
|
-0.1%
|
+1.0%
|
+0.2%
|
|
EXPE
|
Consumer Cyclical |
Gordon Haskett |
Downgrade
|
Buy
→
Hold
|
—
|
$28.4B
|
$161.69
|
-7.5%
|
-7.9%
|
-0.1%
|
-0.1%
|
+1.0%
|
+0.2%
|
|
MRNA
|
Healthcare |
Piper Sandler |
Downgrade
|
Overweight
→
Neutral
|
—
|
$17.8B
|
$416.26
|
-1.4%
|
-0.6%
|
+17.1%
|
-5.7%
|
-15.6%
|
+1.6%
|
|
MRNA
|
Healthcare |
Oppenheimer |
Downgrade
|
Outperform
→
Perform
|
—
|
$17.8B
|
$416.26
|
-1.4%
|
-0.6%
|
+17.1%
|
-5.7%
|
-15.6%
|
+1.6%
|
|
NBIX
|
Healthcare |
Canaccord Genuity |
Downgrade
|
Buy
→
Hold
|
—
|
$15.8B
|
$92.69
|
-1.3%
|
-3.4%
|
-0.8%
|
-1.9%
|
-1.2%
|
+0.6%
|
|
IPGP
|
Technology |
Citigroup |
Downgrade
|
Buy
→
Neutral
|
—
|
$4.8B
|
$183.62
|
-1.4%
|
-1.1%
|
-2.1%
|
-0.5%
|
-2.1%
|
-1.9%
|
|
COLD
|
Real Estate |
Raymond James |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$4.0B
|
$38.73
|
-9.0%
|
-3.9%
|
-2.2%
|
-0.7%
|
+1.9%
|
+0.5%
|
|
ITRI
|
Technology |
Baird |
Downgrade
|
Outperform
→
Neutral
|
—
|
$3.6B
|
$71.84
|
+3.0%
|
+7.3%
|
+0.8%
|
+4.7%
|
+0.3%
|
+1.0%
|
|
BCRX
|
Healthcare |
Jefferies |
Downgrade
|
Buy
→
Hold
|
—
|
$1.9B
|
$17.65
|
+0.8%
|
-0.2%
|
+0.2%
|
-13.8%
|
+2.4%
|
+6.8%
|
|
COLL
|
Healthcare |
Cantor Fitzgerald |
Downgrade
|
Overweight
→
Neutral
|
—
|
$1.3B
|
$24.84
|
-16.2%
|
-17.3%
|
-3.1%
|
-4.4%
|
-2.0%
|
-2.3%
|
|
KPTI
|
Healthcare |
SVB Leerink |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$68M
|
$88.95
|
-0.3%
|
-6.9%
|
+0.9%
|
-0.5%
|
-5.6%
|
-7.8%
|
|
KPTI
|
Healthcare |
JP Morgan |
Downgrade
|
Overweight
→
Underweight
|
—
|
$68M
|
$88.95
|
-0.3%
|
-6.9%
|
+0.9%
|
-0.5%
|
-5.6%
|
-7.8%
|
|
KPTI
|
Healthcare |
RBC Capital |
Downgrade
|
Outperform
→
Sector Perform
|
—
|
$68M
|
$88.95
|
-0.3%
|
-6.9%
|
+0.9%
|
-0.5%
|
-5.6%
|
-7.8%
|
|
KALA
|
Healthcare |
JP Morgan |
Downgrade
|
Overweight
→
Neutral
|
—
|
$58M
|
$159.00
|
-4.6%
|
-1.3%
|
+10.2%
|
-7.8%
|
-0.3%
|
-1.9%
|